| 摘要 |
The invention relates generally to fusion proteins comprising at least one therapeutic protein or vaccine antigen and alpha fetoprotein. The therapeutic protein or vaccine antigen can be, for example, a peptide, antibody, fragment thereof, or variant thereof. The therapeutic protein or vaccine antigen is fused to alpha-fetoprotein, an alpha-fetoprotein fragment, or an alpha-fetoprotein variant. Also encompassed by the invention are nucleic acids encoding the fusion proteins of the invention, vectors comprising such nucleic acids, and host cells transformed with such nucleic acids and/or vectors. Methods of making and using the fusion proteins, nucleic acids, vectors, and host cells are also encompassed by the invention.
|
